Tracking cancer-related fatigue during chemotherapy: Insights from a comparative cohort study of early breast cancer patients
Menée à partir de données portant sur 100 patientes atteintes d'un cancer du sein de stade précoce, cette étude de cohorte analyse l'évolution de la fatigue pendant la chimiothérapie et examine l'effet, sur cette fatigue, de la pratique d'exercices physiques
Cancer-related fatigue (CRF) is a multifactorial symptom commonly experienced by breast cancer patients treated with chemotherapy (CT) that impairs quality of life and may influence cancer recurrence by reducing treatment compliance. This cohort study examined the kinetics of CRF throughout CT in breast cancer patients and determined its relationship with exercise-related variables. One hundred breast cancer patients were included. Three time points were investigated: pre-CT, 8 weeks, and post-CT. Patients were categorized as fatigued or non-fatigued according to their FACIT-F score. Exercise capacity (assessed using the 6-minute walking test), muscle mass and force, neuromuscular fatigue, and physical activity level were measured. Among the seven patterns of CRF trajectories identified, three represented 78% of the fatigued patients. Fatigued patients exhibited reduced exercise capacity compared to non-fatigued patients during CT (p = 0.001). This was associated with greater knee extensor (p < 0.001) and handgrip (p = 0.009) neuromuscular fatigue and lower physical activity level (p < 0.001) in fatigued patients. The model combining knee extensors neuromuscular fatigue (p = 0.007) and force (p = 0.081), 6-minute walking test distance (p < 0.001) and physical activity level (p = 0.029) explained 39% of the variance in the FACIT-F score evolution from pre- to post-CT. The dissociation between fatigued versus non-fatigued patients highlighted that CRF was associated with altered exercise capacity and neuromuscular fatigue. Exercise-related variables seem to play an important role in CRF evolution during CT, suggesting that exercise training should be initiated at the start of CT.
International Journal of Cancer , article en libre accès, 2025